Singapore markets closed

Verve Therapeutics, Inc. (VERV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.76-0.12 (-1.74%)
As of 11:19AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10101010
Avg. Estimate-0.71-0.73-2.93-3.1
Low estimate-0.83-0.85-3.47-3.75
High estimate-0.56-0.6-2.4-2.54
Year ago EPS-0.84-0.87-3.12-2.93
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10101110
Avg. Estimate2.02M2.37M11.83M9.02M
Low estimateN/AN/AN/AN/A
High estimate5.05M8.55M42M24.6M
Year ago sales1.4M2.09M11.76M11.83M
Sales growth (year/est)43.90%13.20%0.60%-23.80%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.78-0.92-0.92-0.82
Actual EPS-0.84-0.87-0.72-0.69
Difference-0.060.050.20.13
Surprise %-7.70%5.40%21.70%15.90%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.71-0.73-2.93-3.1
7 days ago-0.71-0.73-2.93-3.1
30 days ago-0.73-0.74-2.98-3.22
60 days ago-0.83-0.86-3.47-3.59
90 days ago-0.83-0.86-3.47-3.59
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A21
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesVERVIndustrySector(s)S&P 500
Current qtr.15.50%N/AN/AN/A
Next qtr.16.10%N/AN/AN/A
Current year6.10%N/AN/AN/A
Next year-5.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A